SCHEDULE 13G/AAccepted May 15, 10:31 AM ET
Avalo Therapeutics, Inc. SCHEDULE 13G/A
Accepted (ET)
10:31 AM
May 15, 2026
Filed
May 15, 2026
Documents
1
Size
10.1 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.